Effectiveness of clinical and instrumental follow-up for cutaneous melanoma

被引:4
|
作者
Toia, Francesca [1 ]
Cajozzo, Marta [2 ]
Rosatti, Fernando [1 ,5 ]
Di Lorenzo, Sara [1 ]
Rinaldi, Gaetana [3 ]
Mazzucco, Walter [4 ]
Cordova, Adriana [1 ]
机构
[1] Univ Palermo, Dept Surg Oncol & Oral Sci DICHIRONS, Plast & Reconstruct Surg, Palermo, Italy
[2] Bambino Gesu Pediat Hosp, Plast & Maxillofacial Surg Dept, IRCCS, Rome, Italy
[3] Univ Palermo, Dept Surg Oncol & Oral Sci, Sect Med Oncol, Palermo, Italy
[4] Univ Palermo, Dept Hlth Promot Maternal & Infant Care, Internal Med & Med Specialties PROMISE, Palermo, Italy
[5] Univ Palermo, Dept Surg Oncol & Oral Sci, Div Plast & Reconstruct Surg, Via Vespro 129, I-90127 Palermo, Italy
来源
SURGICAL ONCOLOGY-OXFORD | 2022年 / 44卷
关键词
Melanoma; Follow-up; Local recurrences; Metastases; Prognosis; Surgical oncology; LATE RECURRENCE; STAGE IIB; GUIDELINES; DIAGNOSIS; HEAD; TOMOGRAPHY; SOCIETY; CANCER; SFORL;
D O I
10.1016/j.suronc.2022.101821
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Follow-up guidelines for melanoma greatly differ in the methods of screening for recurrence, and timing and duration of the follow up, with many areas of controversy and a lack of general consensus. The aims of this study are to present our protocol and case series for follow up and to summarize and discuss current literature on melanoma follow-up guidelines/recommendations in different countries.Methods: We retrospectively reviewed 539 patients operated for melanoma between 2004 and 2013 at the same Institution. Data on the diagnostic role of the different clinical and instrumental detection methods were adjusted for sex, age at diagnosis, staging and evaluated by Fisher's exact test and multivariate analysis. Recommendations from the literature were summarized and discussed.Results: Local recurrences and second melanoma were always identified through physical examination, irre-spectively of melanoma staging. Regional metastases were most often identified through physical examination and ultrasound, being more frequent in stage II and III, while distant metastases were most often identified through CT scans. Surveillance follow-up schedules vary significantly depending on country, physician specialty, and stage of disease, with a lack of evidence on the efficacy of the different schemes. Similarities and controversies in the different follow-up protocols are presented and discussed.Conclusion: Our clinical series showed that physical examination is very powerful in identifying local recurrences and second melanomas. Physical examination and ultrasound are equally powerful in identifying regional me-tastases, and alternating them over time could allow to reduce the number of follow-up visits. CT scans, differently from chest x-ray, showed a high power in identifying distant metastases. Surveillance follow-up schedules in the literature vary significantly depending on country, physician specialty, and stage of disease, with a lack of evidence on the efficacy of the different schemes. Standard protocols are desirable for a better evaluation of results.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Follow-up for cutaneous malignant melanoma
    Williams, HC
    BRITISH JOURNAL OF DERMATOLOGY, 1999, 141 (04) : 762 - 763
  • [2] Surveillance and follow-up examinations in cutaneous melanoma
    Garbe, C
    Schadendorf, D
    ONKOLOGIE, 2003, 26 (03): : 241 - 246
  • [3] Staging and follow-up of cutaneous melanoma patients
    Garcia-Rodrigo, Carlota Gutierrez
    Antonini, Ambra
    Rocco, Tea
    Pellegrini, Cristina
    Micantonio, Tamara
    Fargnoli, Maria Concetta
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2017, 152 (03): : 231 - 240
  • [4] Follow-up requirements for thick cutaneous melanoma
    Sylaidis, P
    Gordon, D
    Rigby, H
    Kenealy, J
    BRITISH JOURNAL OF PLASTIC SURGERY, 1997, 50 (05): : 349 - 353
  • [5] Cutaneous malignant melanoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
    Jost, L.
    ANNALS OF ONCOLOGY, 2007, 18 : 71 - 73
  • [6] Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Dummer, R.
    Hauschild, A.
    Guggenheim, M.
    Keilholz, U.
    Pentheroudakis, G.
    ANNALS OF ONCOLOGY, 2012, 23 : 86 - 91
  • [7] Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
    Amaral, T.
    Ottaviano, M.
    Arance, A.
    Blank, C.
    Chiarion-Sileni, V.
    Donia, M.
    Dummer, R.
    Garbe, C.
    Gershenwald, J. E.
    Gogas, H.
    Guckenberger, M.
    Haanen, J.
    Hamid, O.
    Hauschild, A.
    Hoeller, C.
    Lebbe, C.
    Lee, R. J.
    Long, G., V
    Lorigan, P.
    Couselo, E. Munoz
    Nathan, P.
    Robert, C.
    Romano, E.
    Schadendorf, D.
    Sondak, V
    Suijkerbuijk, K. P. M.
    van Akkooi, A. C. J.
    Michelin, O.
    Ascierto, P. A.
    ANNALS OF ONCOLOGY, 2025, 36 (01) : 10 - 30
  • [8] Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Michielin, O.
    van Akkooi, A. C. J.
    Ascierto, P. A.
    Dummer, R.
    Keilholz, U.
    ANNALS OF ONCOLOGY, 2019, 30 (12) : 1884 - 1901
  • [9] Cutaneous malignant melanoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
    Dummer, R.
    Hauschild, A.
    Jost, L.
    Grp, E. S. M. O. Guidelines Working
    ANNALS OF ONCOLOGY, 2008, 19 : 86 - 88
  • [10] Cutaneous malignant melanoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
    Dummer, R.
    Hauschild, A.
    Pentheroudakis, G.
    ANNALS OF ONCOLOGY, 2009, 20 : 129 - 131